Analyst Ratings Network logo

OTCMKTS:CCHWF - Columbia Care Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $11.10
  • Forecasted Upside: 57.54 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$7.05 As of 01/19/2021 01:00 AM ET
▼ -0.58 (-7.61%)
1 month | 3 months | 12 months
Get New Columbia Care Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CCHWF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CCHWF

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$11.10
▲ +57.54% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Columbia Care in the last 3 months. The average price target is $11.10, with a high forecast of $13.00 and a low forecast of $7.30. The average price target represents a 57.54% upside from the last price of $7.05.
Buy
The current consensus among 6 investment analysts is to buy stock in Columbia Care.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/30/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/28/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/24/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/22/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/21/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
1/20/2021

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
1/13/2021Echelon Wealth PartnersReiterated RatingBuy$13.00
i
1/8/2021Cantor FitzgeraldInitiated CoverageNeutral$7.30
i
12/23/2020Alliance Global PartnersReiterated RatingBuy
i
9/25/2020Alliance Global PartnersInitiated CoverageBuy
i
9/15/2020Echelon Wealth PartnersReiterated RatingBuy$9.50
i
9/10/2020Canaccord GenuityReiterated RatingBuy$13.00
i
9/9/2020Needham & Company LLCReiterated RatingHold
i
8/25/2020Needham & Company LLCInitiated CoverageHold
i
5/18/2020Canaccord GenuityReiterated RatingBuy$13.00
i
4/28/2020LADENBURG THALM/SH SHInitiated CoverageBuy
i
(Data available from 1/20/2016 forward)
Columbia Care logo
Columbia Care Inc. cultivates, manufactures, and provides medical and adult use cannabis products and related services. The company holds licenses in 18 jurisdictions in the United States and the European Union. It operates a medical cannabis dispensary in New Jersey. The company was founded in 2012 and is headquartered in New York, New York.
Read More

Today's Range

Now: $7.05
$7.00
$7.74

50 Day Range

MA: $5.64
$4.25
$7.63

52 Week Range

Now: $7.05
$0.78
$7.74

Volume

1,217,497 shs

Average Volume

1,273,695 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Columbia Care?

The following Wall Street analysts have issued research reports on Columbia Care in the last twelve months: Alliance Global Partners, Canaccord Genuity, Cantor Fitzgerald, Echelon Wealth Partners, LADENBURG THALM/SH SH, and Needham & Company LLC.

What is the current price target for Columbia Care?

3 Wall Street analysts have set twelve-month price targets for Columbia Care in the last year. Their average twelve-month price target is $11.10, suggesting a possible upside of 57.5%. Canaccord Genuity has the highest price target set, predicting CCHWF will reach $13.00 in the next twelve months. Cantor Fitzgerald has the lowest price target set, forecasting a price of $7.30 for Columbia Care in the next year.

What is the current consensus analyst rating for Columbia Care?

Columbia Care currently has 2 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CCHWF will outperform the market and that investors should add to their positions of Columbia Care.

What other companies compete with Columbia Care?

Other companies that are similar to Columbia Care include (CSI), (IMCC), 1933 Industries, 28896, AB Science, Abattis Bioceuticals, Acreage, AFT Pharmaceuticals Limited (AFP.AX), Agraflora Organics International, AgraFlora Organics International, Aleafia Health, American Green, Australian Primary Hemp Limited (APH.AX), Ayr Strategies and Benitec Biopharma.